Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy

Overview of attention for article published in Journal of Cancer Research and Clinical Oncology, December 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 16,400 followers.

Single center study suggests disease burden, NK-cell count and SLAMF7 expression on #myeloma cells may help to define #myeloma patients with high likelihood to respond to #Empliciti treatment: https://t.co/4J44HpHycm. https://t.co/koG1HDyoqj

09 Dec 2018

Reply Repost Favourite

Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy. by Danhof S, Strifler S, Hose D, Kortüm M, Bittrich M, Hefner J, Einsele H, Knop S, Schreder M https://t.co/vBfULYIj1d

07 Dec 2018

Reply Repost Favourite